Combat & Casualty Care

Q1 2016

Military Magazines in the United States and Canada, Covering Combat and Casualty Care, first responders, rescue and medical products programs and news\Tactical Defense Media

Issue link: http://combatcasualtycare.epubxp.com/i/678582

Contents of this Issue

Navigation

Page 13 of 35

tacticaldefensemedia.com 12 | Combat & Casualty Care | Spring 2016 Industry Partner Hemorrhage Control The United States Army Institute of Surgical Research (USAISR) reports that 30 to 40 percent of civilian deaths by traumatic injury are the result of hemorrhaging; of those deaths, 33 to 56 percent occur before the patient reaches an emergency care facility. By Will Fox, M.B.A., Vice President, Sales & Marketing, RevMedx and Pamela Jackson, COO & Co-Founder, Panakeia T he Department of Homeland Security (DHS) is working to educate the general public on how to be prepared to address severe bleeding from traumatic injury. Through its "Stop the Bleed " campaign (w w w.dhs.gov/stopthebleed) they are helping to raise awareness of the importance for early control of severe bleeding to help prevent shock and save lives. RevMedx, a Portland-based medical device company has dedicated itself to saving lives by creating groundbreaking medical products. They've developed an entire line of devices designed specifically for combat medics and civilian first responders to revolutionize the treatment of traumatic bleeding. Their partner, Panakeia, LLC is also focused on this goal by providing medical solutions that transform patient care and save lives. They distribute innovative medical products to the global medical community, including the military, pre- hospital care and EMS, law enforcement, fire/rescue, Veteran's Administration and hospital critical care. Panakeia was also recently awarded a General Services Administration (GSA) Federal Supply Schedule (FSS) to add the full line of RevMedx products for the next five years. This allows the military medical community another contract vehicle to purchase RevMedx products through Panakeia. Additional products now available include the Parabelt, a daily-wear belt with integrated ratcheting tourniquet, the Sharkbite Trauma Kit for the treatment of large blast injuries, and XGauze, a z-folded dressing embedded with expanding sponges.The FSS contract number is: V797D40152. RevMedx Vice President John Steinbaugh served in the U.S. Army for 25 years—20 of which he spent as a Special Forces medic with multiple tours of duty in Iraq and Afghanistan. Steinbaugh worked with medics returning from the battlefield that were not happy with the results of traditional hemostatic treatments. Medics wanted a quicker solution to severe junctional bleeding of the axilla and groin. Steinbaugh and his team set out to invent a portable, quick solution to allow the medic to inject material into the wound that would immediately stop bleeding without direct pressure. With feedback from medics along the entire design process the XSTAT hemorrhage control device was created. New Solution for Critical Wound Care Recently cleared by the FDA for civilian use, the XSTAT is a first-in-kind hemostatic device for the treatment of severe bleeding in the axilla or groin area where tourniquets or other methods are inadequate. It consists of a 30mm diameter syringe filled with 92 compressed mini-sponges, treated with a hemostatic agent – chitosan, as well as a radiopaque marker for visibility under imaging. These sponges, when in contact with blood or f luid, expand up to 10x their size and create a temporary barrier to blood f low. The compact syringe features a telescoping handle to quick ly inject the sponges to the injury site. The rapid expansion of the sponges provides for internal compressive forces in the wound area to control bleeding until the patient can receive surgical care. Additionally, no manual compression is required after deployment, although a cover bandage is recommended. Wound packing time based on testing results show that XSTAT took medics 25% of the time required to pack the wound and to reach hemostasis versus traditional methods using gauze. Because these sponges directly apply pressure from the inside, medics no longer need to spend three to five minutes applying pressure to the wound, waiting for the bleeding to stop. Or even worse, if the bleeding does not stop after the first attempt, the medic will have to remove used ANSWERING THE NEED TO STOP THE BLEED

Articles in this issue

Links on this page

Archives of this issue

view archives of Combat & Casualty Care - Q1 2016